<<< Back to main document

Class Action - Statins Increases Heart Disease By 10% in Women

 

"...women who are taking Lipitor without heart disease actually developed 10 percent more heart attacks than women treated with a placebo."

I repeatedly get questions on what one should do if they are having side effects and/or have been told by there MD's to lower their cholesterol. The conditioning is so strong that most repeatedly over look the damaging evidence of the said drugs and continue to feel they are doomed if their cholesterol is even slightly high. Hopefully this will settle the question once and for all. The side effects are a sign of toxicity of the drugs and hence should be stopped. Cholesterol in the main is not the cause of heart disease but can be a symptom of heart disease and is often protective. Lowering it in many cases, as shown here, can be more detrimental the leaving it alone!

For those struggling with issues on statins (cholesterol lowering drugs); here is a clear cut example on why these drugs are not the answer and an opportunity to participate in the class action for those who feel duped which have been!


See also:

Frequently Asked Questions About Statins

Frequently Asked Questions About Statins

Pfizer Sued in California: Covering up Zoloft Side Effects

WHO-US Adverse Reaction Reports For Statins - When Where What?

Chris Gupta
http://tinyurl.com/s8v43
-------------------------------

"Consumers have filed the first-of-its-kind, nationwide class action lawsuit against Pfizer, maker of the popular cholesterol-lowering, statin-type drug Lipitor. The lawsuit alleges that Pfizer engaged in a massive campaign to convince both doctors and patients that Lipitor is a beneficial treatment for nearly everyone with elevated cholesterol, even though no studies have shown it to be effective for those over 65, and for women at any age who do not already have heart disease or diabetes. In fact, the ASCOT study, the largest clinical trial on the effectiveness of statin therapy in women, found that women at increased risk of developing heart disease who took Lipitor developed 10 percent more heart attacks than the women who took the placebo. The proposed class action seeks to represent women who have taken Lipitor and who have no history of heart disease or diabetes: people aged 65 and over who have taken Lipitor and who have no history of heart disease or diabetes; and third-party payers such as insurance companies, union health and welfare funds, self-insured employers and others who paid for Lipitor for patients in either of these two groups. The law suit was filed in US District Court in Boston by Steve Berman, managing partner of Hagens Berman Sobol Shapiro on behalf of several individuals. Health Care of All and the Teamsters. For further information see www.hbsslaw.com"

Extracted from: Wise Traditions Journal Volume 6 Number Three Fall 2005
----------------------------------

Date Filed: September 28, 2005
Court: U.S. District Court
Location: Boston
Ticker Symbol: PFE

Join This Suit
Tell a Friend

Hagens Berman Sobol Shapiro has filed a nationwide class-action lawsuit on behalf of individual consumers, a number of labor unions and senior advocacy organizations who purchased the drug LipitorŪ. The suit claims that the drug's manufacturer, Pfizer, Inc. (NYSE: PFE), misled consumers about the benefits of Lipitor through deceptive marketing and advertising activities.

Lipitor is in the class of cholesterol-lowering drugs called statins and is the best-selling drug in the world. In 2004 Lipitor sales reached more than $10 billion. It is estimated that out of the 2004 sales, billions came from patients who do not benefit from the drug.

According to the complaint, Pfizer launched a massive campaign to convince the public that Lipitor is a beneficial treatment for nearly everyone with elevated cholesterol, even though no studies have shown it to be effective for women and those over 65 years of age who do not already have heart disease or diabetes. In fact, there is evidence that women who are taking Lipitor without heart disease actually developed 10 percent more heart attacks than women treated with a placebo.

The lawsuit alleges that Pfizer violated state consumer protection laws against deceptive advertising and seeks to represent women under 65 who have taken Lipitor and who have no history of heart disease or diabetes; people aged 65 and over who have taken Lipitor and who have no history of heart disease or diabetes; and third party payers such as insurance companies, union health and welfare funds, self-insured employers and others, who paid for Lipitor for patients in either of these two groups.

For more information, read the complaint here.

For additional information, please visit www.lipitor-classaction.com, a Web site dedicated to raising awareness of this issue.